Logo image of VROY.CA

VIZSLA ROYALTIES CORP (VROY.CA) Stock Fundamental Analysis

Canada - TSX-V:VROY - CA92859L2012 - Common Stock

4 CAD
-0.38 (-8.68%)
Last: 10/21/2025, 7:00:00 PM
Fundamental Rating

3

Overall VROY gets a fundamental rating of 3 out of 10. We evaluated VROY against 805 industry peers in the Metals & Mining industry. While VROY has a great health rating, there are worries on its profitability. VROY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VROY had negative earnings in the past year.
VROY had a negative operating cash flow in the past year.
VROY.CA Yearly Net Income VS EBIT VS OCF VS FCFVROY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 -1M -2M -3M

1.2 Ratios

VROY has a better Return On Assets (-9.80%) than 60.50% of its industry peers.
With a decent Return On Equity value of -9.82%, VROY is doing good in the industry, outperforming 64.60% of the companies in the same industry.
Industry RankSector Rank
ROA -9.8%
ROE -9.82%
ROIC N/A
ROA(3y)-33.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VROY.CA Yearly ROA, ROE, ROICVROY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 -20 -40 -60

1.3 Margins

VROY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VROY.CA Yearly Profit, Operating, Gross MarginsVROY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for VROY has been increased compared to 1 year ago.
There is no outstanding debt for VROY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VROY.CA Yearly Shares OutstandingVROY.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 10M 20M 30M
VROY.CA Yearly Total Debt VS Total AssetsVROY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 2M 4M 6M

2.2 Solvency

An Altman-Z score of 1604.64 indicates that VROY is not in any danger for bankruptcy at the moment.
VROY has a Altman-Z score of 1604.64. This is amongst the best in the industry. VROY outperforms 99.63% of its industry peers.
VROY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1604.64
ROIC/WACCN/A
WACCN/A
VROY.CA Yearly LT Debt VS Equity VS FCFVROY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 112.93 indicates that VROY has no problem at all paying its short term obligations.
The Current ratio of VROY (112.93) is better than 98.76% of its industry peers.
A Quick Ratio of 112.93 indicates that VROY has no problem at all paying its short term obligations.
The Quick ratio of VROY (112.93) is better than 98.76% of its industry peers.
Industry RankSector Rank
Current Ratio 112.93
Quick Ratio 112.93
VROY.CA Yearly Current Assets VS Current LiabilitesVROY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for VROY have decreased strongly by -1921.54% in the last year.
EPS 1Y (TTM)-1921.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 65.87% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y37.85%
EPS Next 2Y26.95%
EPS Next 3Y65.87%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VROY.CA Yearly Revenue VS EstimatesVROY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2M 4M 6M 8M
VROY.CA Yearly EPS VS EstimatesVROY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.05 -0.05 0.1 -0.1 0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VROY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VROY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VROY.CA Price Earnings VS Forward Price EarningsVROY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VROY.CA Per share dataVROY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

VROY's earnings are expected to grow with 65.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.95%
EPS Next 3Y65.87%

More info and screens

0

5. Dividend

5.1 Amount

VROY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIZSLA ROYALTIES CORP

TSX-V:VROY (10/21/2025, 7:00:00 PM)

4

-0.38 (-8.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-26 2025-09-26/dmh
Earnings (Next)N/A N/A
Inst Owners9.95%
Inst Owner ChangeN/A
Ins Owners3.3%
Ins Owner ChangeN/A
Market Cap267.96M
Analysts80
Price Target3.95 (-1.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)19.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-100%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.01
P/tB 4.01
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0
BVpS1
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.8%
ROE -9.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-33.45%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 112.93
Quick Ratio 112.93
Altman-Z 1604.64
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1921.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.55%
EPS Next Y37.85%
EPS Next 2Y26.95%
EPS Next 3Y65.87%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1822.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-18.75%
EBIT Next 3Y200.7%
EBIT Next 5YN/A
FCF growth 1Y-437.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-437.28%
OCF growth 3YN/A
OCF growth 5YN/A